LOS ANGELES, March 18 /PRNewswire/ -- A unique, high-sensitivity, double
surgical glove that saves time and money will be debuted at the Association of
periOperative Registered Nurses (AORN) Congress in San Diego, March 20-25, 2004. The glove was developed by Bio-Barrier Inc., an infection control technology company
based in Los Angeles.
The new glove features two separate layers originating from a single cuff
at the wrist. It is more comfortable than wearing two separate gloves, a practice common among surgeons and nurses who recognize
that two layers of barrier help wipe off more pathogens from a needlestick or
sharps injury than a single layer. Several studies confirm the relationship
between double gloves and the reduction in pathogens. The company's patents
allow the glove to be made of thin layers of latex or polymer while utilizing
current powder-free technologies.
According to the company, the double glove will save time and money for
hospitals and medical practices by reducing the time associated with double
donning, by reducing the amount of packaging currently used for single glove
sets, and by reducing inventory, storage and waste.
Bio-Barrier holds more than 20 U.S. and international thin-film patents that
address new dipping processes for latex and polymer thin films. These patents
significantly expand the potential array of protective products available to
healthcare and humanitarian workers. Product applications include surgical,
exam and occupational gloves, first responder equipment, and personal
protection coverings such as condoms.
Prototypes of the new double surgical glove will be available in the
Bio-Barrier exhibit at the AORN Congress, Booth #3807.
Source: Bio-Barrier Inc.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.
Our Understanding of Immune Issues Is Evolving: Here Are 5 Reasons Why
October 25th 2024The past 5 years in medicine have seen significant advances in RNA vaccines, understanding immune dysregulation, and improved interspecialty communication, promising better disease eradication and tailored treatments.
Long COVID: Urgent Findings, Including Brain Alterations, Call for Renewed Public Health Focus
October 21st 2024New research highlights long COVID’s global impact, cognitive decline, and societal consequences, urging renewed focus on prevention, including vaccination, mask use, and better air quality.